Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)
NCT01502982
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
160
Enrollment
NETWORK
Sponsor class
Conditions
Diffuse Large B-Cell Lymphoma
Interventions
DRUG:
R-CHOEP14x6+HD-AraC+HD-Mtx
Sponsor
Nordic Lymphoma Group
Collaborators
[object Object]